Navigation Links
InfoLogix Announces First Quarter 2008 Financial Results

- Revenue for the first quarter increased 80.6% compared to the first

quarter 2007 to $23.8 million - Gross profit for the first quarter increased by 85.7% compared to the

first quarter of 2007 to $6.2 million

- Achieved highest quarterly revenue in Company history

HATBORO, Pa., April 30 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced financial results for the first quarter ended March 31, 2008. The Company reported total revenue of $23.8 million, compared to $13.2 million for the first quarter of 2007, an increase of $10.6 million or 80.6%.

(Logo: )

"We are pleased with the Company's financial performance in the first quarter," stated David Gulian, President and Chief Executive Officer of InfoLogix. "The Company has achieved its highest quarterly revenue since we started the business in 2001. The first quarter has historically been seasonally low, which makes our revenue growth in 2008 a significant milestone for the Company. For the first time in our history, we have experienced sequential revenue growth from fourth quarter to first quarter. In addition, our strong growth provides an encouraging outlook and a solid base for 2008 as we approach $100 million in annual revenue."

First Quarter 2008 Financial Results

Revenues were $23.8 million for the quarter ended March 31, 2008, compared to $13.2 million for the same period of 2007, an increase of $10.6 million or 80.6%. The increase in revenue is the result of the expanded solution-oriented sales staff and their results of increasing mobile point-of-care solutions in healthcare, the resale of wireless infrastructure, and the expansion of professional services across the organization.

Gross profit was $6.2 million for the quarter ended March 31, 2008, compared to $3.3 million for the same period of 2007, an increase of $2.9 million or 85.7%. For the quarter ended March 31, 2008, gross margin was 26.1%, up from 25.4% for the first quarter of 2007. The increase in gross margin is the result of an increase in sales of more profitable professional and consulting services, partially offset by an increase in sales of lower margin third-party hardware.

Selling expenses were $3.2 million for the quarter ended March 31, 2008, compared to $2.1 million in the first quarter 2007, an increase of $1.1 million or 51.6%. The increase in selling expenses is the result of the expanded solution-oriented sales staff and related travel and greater commission payments resulting from increased sales. General and administrative expenses were $4.3 million for the quarter ended March 31, 2008, compared with $3.0 million for the same period of 2007, an increase of $1.3 million, or 40.7%. The increase in general and administrative expenses was primarily attributable to increased wages related to the higher number of management, administrative and sales support staff.

InfoLogix reported a net loss of $1.0 million, or $0.04 per basic and diluted share, for the three months ended March 31, 2008 compared with a net loss of $1.1 million, or $0.05 per basic and diluted share for the same period of 2007, a decrease of $0.1 million or 9.9%.

"We believe our strong revenue growth, increasing gross margins, and operating efficiencies will allow us to reach profitability in the second half of 2008," stated Mr. Gulian. "During the first quarter, our margins were slightly impacted by the sale of lower margin hardware to several legacy accounts. Moving forward, we will continue to work towards increasing the sales of our more profitable mobile solutions and professional and consulting services as we drive toward our goal of exceeding 30% margins, and capitalizing on our operating leverage to reach profitability."


InfoLogix intends to remain focused on its previously stated strategies for growth and expansion in 2008:

-- Key Acquisitions: Focus on potential acquisitions, opportunities as

well as continue the integration of the Healthcare Informatics

Associates and AMT Systems acquisitions.

-- Organic Revenue Growth: Continue to capitalize on the newly trained

and fully capable sales force in order to increase market penetration

and revenue growth.

-- Service Line Mix: Increase sales of higher margin service lines such

as solution sales and professional and consulting services which will

assist in improving InfoLogix's bottom-line.

-- Proprietary Offerings: Continue to develop and deliver new applications

and software offerings centered around mobility and RFID. This will

allow InfoLogix to strengthen its brand recognition and customer


-- Optimize Operations: Rely on its experienced management team in order

to maximize the financial success of operations and achieve strong


"We are excited with the strong start to the fiscal year and eager to continue the momentum from our record revenue," Mr. Gulian stated. "InfoLogix is dedicated to being the premier provider of enterprise mobility solutions for the healthcare and commercial industries. We will remain committed to our growth and expansion initiatives as we continue to focus on reaching profitability and creating stockholder value."

Conference Call and Webcast

Management will host a conference call with the investment community today, April 30, 2008 at 4:30 p.m. Eastern time. Interested parties may participate in the teleconference by pre-registering (This allows participants and speakers to pre-register for the call) at and dialing (888) 680-0879 or (617) 213-4856 for international callers. When prompted, ask for the "First Quarter InfoLogix Earnings Conference Call." A telephonic replay may be accessed approximately two hours after the call through May 7, 2008, by dialing (888) 286-8010 or (617) 801-6888 for international callers and entering the replay access code 28250282. The teleconference will be webcast simultaneously on the InfoLogix website at under Investors: Event Calendar. The webcast replay will be archived for 12 months.

About InfoLogix, Inc.

InfoLogix is a leading provider of technology and RFID based intelligence solutions that enable the mobile enterprise. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes for the healthcare industry and the commercial marketplace. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). For more information, visit

Safe Harbor

InfoLogix makes forward-looking statements in this press release which represent our expectations or beliefs about future events and financial performance. Forward-looking statements are identifiable by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, including the risks described in our Annual Report on Form 10-K for the period ended December 31, 2007 and other filings we make with the Securities and Exchange Commission. In addition, actual results could differ materially from those suggested by the forward- looking statements, and therefore you should not place undue reliance on the forward-looking statements. We do not make any commitment to revise or update any forward-looking statements to reflect events or circumstances occurring or existing after the date of any forward-looking statement is made.



March 31, December 31,

2008 2007



Currents assets:

Cash and cash equivalents $5,059 $6,101

Accounts and other receivables (net of allowance

for doubtful accounts in the amount of $495 and

$409 as of March 31, 2008 and December 31, 2007,

respectively) 20,118 20,301

Unbilled revenue 1,421 1,052

Finished goods inventory, net 1,680 1,899

Prepaid expenses and other current assets 843 603

Promissory notes receivable 202 -

Deferred tax assets - current 532 451

Total current assets 29,855 30,407

Property and equipment, net 1,535 1,247

Intangible assets, net 7,946 8,362

Goodwill 5,668 5,668

Deferred tax assets - long-term 3,461 2,956

Deferred financing costs 53 57

Total assets $48,518 $48,697


Current liabilities:

Accounts payable $9,967 $8,650

Line of credit 9,425 9,959

Current portion of notes payable 740 627

Current portion of capital lease obligations 126 139

Sales tax payable 244 299

Accrued expenses 3,394 3,560

Deferred revenue 86 75

Total current liabilities 23,982 23,309

Notes payable, net of current maturities 6,711 6,818

Capital lease obligations, net of current maturities 74 94

Total liabilities 30,767 30,221

Commitments and Contingencies

Stockholders' equity:

Preferred stock, par value $.00001; authorized

10,000,000 shares; none issued or outstanding - -

Common stock, par value $.00001; authorized

100,000,000 shares; issued and outstanding

24,919,301 shares and 24,909,301 shares at

March 31, 2008 and December 31, 2007, respectively - -

Additional paid in capital 23,846 23,580

Accumulated deficit (6,095) (5,104)

Total stockholders' equity 17,751 18,476

Total liabilities and stockholders' equity $48,518 $48,697



Three Months Ended March 31,

2008 2007

Revenues $23,786 $13,174

Cost of revenues 17,581 9,833

Gross profit 6,205 3,341

Selling, general and administrative expenses 7,517 5,177

Operating loss (1,312) (1,836)

Interest expense (286) (131)

Interest income 48 158

Loss before income tax benefits (1,550) (1,809)

Income tax benefit 559 709

Net loss $(991) $(1,100)

Loss per share - basic and diluted $(0.04) $(0.05)

Weighted average shares outstanding - basic

and diluted 24,918,441 23,595,663



Three Months Ended March 31,

2008 2007

Operating activities:

Net loss $(991) $(1,100)

Adjustments to reconcile net loss to

operating cash flow:

Depreciation and amortization 533 287

Allowance for doubtful accounts receivable 86 16

Inventory obsolescence 123 -

Amortization of deferred financing costs 4 -

Accrued interest expense added to note

payable 79 -

Accrued interest income added to note

receivable (2) -

Share based compensation and other share

based payments 266 250

Deferred income tax benefit (586) (709)

Changes in:

Accounts receivable 97 1,594

Unbilled revenue (369) -

Inventory 96 (45)

Prepaid expenses and other current assets (240) (146)

Accounts payable 1,317 (1,597)

Sales tax payable (55) (105)

Accrued expenses (165) 353

Deferred revenue 11 -

Net cash provided by (used in) operating

activities 204 (1,202)

Investing activities:

Acquisition of property, software and

equipment (405) (524)

Promissory notes issued (200) -

Net cash used in investing activities (605) (524)

Financing activities:

Repayment of long-term debt and capital leases (107) (200)

(Repayments) borrowings on line of credit (534) 570

Net cash (used in) provided by financing

activities (641) 370

Net change in cash and cash equivalents (1,042) (1,356)

Cash and cash equivalents at beginning of

period 6,101 12,882

Cash and cash equivalents at end of period $5,059 $11,526

SOURCE InfoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. InfoLogix to Report First Quarter Results on April 30, 2008
2. Dollar Thrifty Automotive Group Expands Mobile Managed Services Contract with InfoLogix
3. InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
4. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
5. InfoLogix to Report Third Quarter and Nine Month Financial Results on November 8, 2007
6. InfoLogix Signs Largest International Deal to Date with Healthcare Solutions Agreement in United Arab Emirates
7. InfoLogix Acquires Healthcare Informatics Associates Inc. (HIA); Adds Premier Healthcare Consulting Firm and Systems Integrator
8. InfoLogix Announces Approval for NASDAQ Listing
9. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
10. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
11. ATS Medical Announces First Frontiers in Cryoablation Symposium
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology: